Zi‐Yang Peng

机构：National Cheng Kung University

发表论文 15 篇 · 总被引 163 次 · h-index 7

代表论文

• Lower risks of cirrhosis and hepatocellular carcinoma with GLP‐1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework (2023 · Journal of Internal Medicine · 被引 41)
• Restricted Mean Survival Time Analysis to Estimate SGLT2i–Associated Heterogeneous Treatment Effects on Primary and Secondary Prevention of Cardiorenal Outcomes in Patients With Type 2 Diabetes in Taiwan (2022 · JAMA Network Open · 被引 23)
• Reduced All‐Cause Mortality With Bisphosphonates Among Post‐Fracture Osteoporosis Patients: A Nationwide Study and Systematic Review (2022 · Clinical Pharmacology & Therapeutics · 被引 22)
• Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study (2023 · Cardiovascular Diabetology · 被引 19)
• Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review (2022 · Frontiers in Endocrinology · 被引 19)
• Reduced risks of influenza-associated hospitalization and complications following vaccination among over 2 million older individuals: a nationwide study using target trial emulation framework (2025 · BMC Medicine · 被引 13)